Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC35H50N2O11 |
InChIKeyPXOYKBPAZLTGIM-MWDQGIJKSA-N |
CAS Registry2254798-39-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | CZ | 03 Oct 2024 |